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In vertebrates, Grb2-associated binder (Gab)1–3 consti-
tute a family of conserved docking proteins. Gab2 is tyro-
sine-phosphorylated upon activation of a variety of
growth factor, hormone, antigen, cytokine and cell matrix
receptors, leading to the recruitment of specific src homol-
ogy (SH)2 domain-containing effectors, which include
the p85 subunit of phosphatidylinositol (PI)3-kinase and
the protein tyrosine phosphatase Shp2. These Gab2 effec-
tors potentiate the activation of the PI3-K/AKT and Ras/
ERK pathways, respectively. Studies using gene knock-out
mice indicate that Gab2 is required for normal mast cell-
mediated allergic responses and osteoclast differentiation,
and in combination with Gab1, for cardiac function. In
addition, Gab2 signals downstream of several oncogenic
tyrosine kinases, and are overexpressed in breast cancer,
and promotes erbB2-induced mammary tumourigenesis.
Therefore, it is critical to define how Gab2 signalling is
regulated in normal and pathological states. One critical
event in Gab2 signalling is its interaction with the adaptor
protein Grb2, which promotes its association with specific
receptors and thereby sustains its tyrosine phosphoryla-
tion dependent recruitment of the aforementioned effec-
tors. However, the molecular mechanisms that attenuate
or limit Gab2 signals have remained unclear.
In the presented study, we have addressed Gab2 regula-
tion using an integrated approach that combines a pro-
teomics-based definition of the Gab2 'phosphomap" with
bioinformatics, biochemistry and cell biology. Here we
report the discovery of 21 novel phosphorylation sites on
human Gab2. Furthermore, we demonstrate that growth
factor-induced and PI3K-dependent phosphorylation of
Gab2 on two of these novel residues, S210 and T391,
leads to recruitment of 14-3-3 proteins. These events
mediate negative feedback regulation, since a Gab2
mutant that cannot be phosphorylated on these sites
exhibits sustained receptor association and signalling, and
promotes cell proliferation and transformation. Impor-
tantly, site-specific introduction of constitutive 14-3-3
binding sites into Gab2 renders it refractory to receptor
activation, demonstrating that site-selective binding of
14-3-3 proteins is sufficient to terminate Gab2 signalling.
Furthermore, this is associated with drastically reduced
recruitment of Grb2 to the Gab2 signalosome suggesting
a competition between 14-3-3 and Grb2 for Gab2 bind-
ing. These findings lead to a model where signal attenua-
tion occurs, because 14-3-3 promotes dissociation of
Gab2 from Grb2, and thereby uncouples Gab2 from the
receptor complex. This represents a novel regulatory
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mechanism with implications for diverse tyrosine kinase
signalling systems in various cell types.Page 2 of 2
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